Causes of fever in pregnant women with acute undifferentiated fever: a prospective multicentric study.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
May 2020
Historique:
received: 12 11 2019
accepted: 26 12 2019
pubmed: 20 1 2020
medline: 15 12 2020
entrez: 20 1 2020
Statut: ppublish

Résumé

The etiologies of undifferentiated fever in pregnant women have not been studied thoroughly. Because of its non-specific presentation but severe prognosis, listeriosis is often suspected in this setting, but in most cases not confirmed. We studied the causes of undifferentiated fever in pregnant women who received preemptive listeriosis treatment. We conducted from November 1, 2011, to June 30, 2013, a prospective multicentric observational cohort study of pregnant women referred to obstetrical wards with undifferentiated fever and who received listeriosis preemptive treatment. Clinical and biological features, treatment, outcome, and final diagnosis were collected. We enrolled 103 febrile pregnant women. A cause was identified in 77/103 (75%): viral infection in 52/103 (50%, influenza in 21 (20%)), bacterial infection in 22 (21%, including 16 pyelonephritis (16%) and 3 pneumonias (3%)), and TORCH infection in 3 (3%, varicella, toxoplasmosis, and cytomegalovirus primo-infections, n=1, each). Viral infections collected during influenza outbreaks (December-March) accounted for 43/57 (75%) cases. Two fetal losses were reported in the context of febrile pneumonia. Final diagnoses required adapting medical care in 46/77 (60%) of cases, for bacterial, influenza, or TORCH infections. A large array of benign to potentially severe infections manifests as acute undifferentiated fever in pregnant women, requiring careful repeated evaluation.

Identifiants

pubmed: 31955353
doi: 10.1007/s10096-019-03809-3
pii: 10.1007/s10096-019-03809-3
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1002

Références

Clin Microbiol Infect. 2014 Dec;20(12):O1035-41
pubmed: 24979689
Lancet Infect Dis. 2015 Oct;15(10):1128-1130
pubmed: 26461937
Med Mal Infect. 2018 Aug;48(5):327-358
pubmed: 29759852
Anaesth Crit Care Pain Med. 2016 Oct;35 Suppl 1:S5-S12
pubmed: 27386764
Rev Obstet Gynecol. 2008 Fall;1(4):179-85
pubmed: 19173022
Clin Infect Dis. 2014 Oct;59(7):953-61
pubmed: 24973315
Lancet Infect Dis. 2017 May;17(5):510-519
pubmed: 28139432
Isr Med Assoc J. 2002 Oct;4(10):776-80
pubmed: 12389339
Obstet Gynecol. 2014 Dec;124(6):1241-4
pubmed: 25411758
Medicine (Baltimore). 2002 Jul;81(4):260-9
pubmed: 12169881
Rev Prat. 2018 Sep;68(7):e277-e282
pubmed: 30869340
Clin Microbiol Infect. 2014 Mar;20(3):246-9
pubmed: 23829227

Auteurs

Caroline Charlier (C)

Institut Pasteur, Biology of Infection Unit, Paris, France. caroline.charlier@pasteur.fr.
Inserm U1117, Paris, France. caroline.charlier@pasteur.fr.
Institut Pasteur, French National Reference Center and WHO Collaborating Center for Listeria, Paris, France. caroline.charlier@pasteur.fr.
Université de Paris, Hôpital Universitaire Necker-Enfants Malades, Division of Infectious Diseases and Tropical Medicine, Assistance Publique-Hôpitaux de Paris, Institut Imagine, Paris, France. caroline.charlier@pasteur.fr.

Elodie Perrodeau (E)

Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité, METHODS Team, UMR 1153, Inserm, Université de Paris, Paris, France.

Camille Levallois (C)

Institut Pasteur, Biology of Infection Unit, Paris, France.
Inserm U1117, Paris, France.

Thierry Cachina (T)

Institut Pasteur, Biology of Infection Unit, Paris, France.
Inserm U1117, Paris, France.

Marc Dommergues (M)

Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie University, Pitié Salpêtrière University Hospital, Paris, France.

Laurent J Salomon (LJ)

Université de Paris, Hôpital Universitaire Necker-Enfants Malades, Division of Infectious Diseases and Tropical Medicine, Assistance Publique-Hôpitaux de Paris, Institut Imagine, Paris, France.

Elie Azria (E)

Inserm U1117, Paris, France.
Maternity Unit, Paris Saint Joseph Hospital, Université de Paris, Paris, France.

François Goffinet (F)

Institut Pasteur, French National Reference Center and WHO Collaborating Center for Listeria, Paris, France.
Hôpital Cochin Port Royal, Port Royal Maternity, Department of Obstetrics, Cochin Port Royal Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.

Philippe Ravaud (P)

Institut Pasteur, French National Reference Center and WHO Collaborating Center for Listeria, Paris, France.
Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité, METHODS Team, UMR 1153, Inserm, Université de Paris, Paris, France.

Marc Lecuit (M)

Institut Pasteur, Biology of Infection Unit, Paris, France. marc.lecuit@pasteur.fr.
Inserm U1117, Paris, France. marc.lecuit@pasteur.fr.
Institut Pasteur, French National Reference Center and WHO Collaborating Center for Listeria, Paris, France. marc.lecuit@pasteur.fr.
Université de Paris, Hôpital Universitaire Necker-Enfants Malades, Division of Infectious Diseases and Tropical Medicine, Assistance Publique-Hôpitaux de Paris, Institut Imagine, Paris, France. marc.lecuit@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH